Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
A study analyzing 1,154 children and adolescents breaks new ground in how to think about the growing diagnosis. (Cha, 4/30)
Respiratory syncytial virus (RSV), mostly infects the lungs, nose, throat, and respiratory tract, and can cause illness ranging from mild cold and fever-like symptoms to severe pneumonia and bronchitis. A recent study has found that having a respiratory infection can act as a shield against the spread of cancer cells. (Mondal, 4/29)
Scientists have developed a way to turn the body's own immune cells into cancer-fighting agents—without removing them from the body—by using red blood cells to deliver genetic instructions. Current CAR (chimeric antigen receptor) therapies typically involve collecting a patient's T cells, genetically modifying them in the laboratory, and then reinfusing them in a process that can take weeks. The new strategy aims to bypass that step. (Ricks, 4/29)
Glioblastoma (GBM) is an aggressive type of brain cancer that is known to be very difficult to treat. One reason why this type of cancer is often resistant to available treatments is that it is characterized by a highly diverse cellular structure and complex interactions between cancerous cells and neighboring healthy cells. (Fadelli, 4/29)
Mediastinal lymph node clearance in stage III non-small cell lung cancer (NSCLC) more than doubled with the addition of immunotherapy to chemotherapy and facilitated more complete surgery, a small prospective study showed. (Bankhead, 4/29)
Scientists at UC San Francisco have discovered that these "brain blips" are not random events, as had been believed. Rather, they unfold in a predictable pattern that can be detected a full second before they occur — raising new possibilities to ward them off altogether. (4/30)